José Roberto Trujillo is a Mexican American physician and scientist in the fields of neuroscience and molecular virology. He is the Founder, Chairman, and CEO of NeuroCytonix Inc., a biomedical technology company focused on exploring and researching solutions for neurological disorders.
Trujillo obtained his Doctor of Science degree in Neurosciences and Molecular Virology at Harvard University in 1995. He was the first doctoral student at Harvard University to combine the studies of neuroscience and virology and is well known as a pioneer in molecular neurovirology at Harvard. Dr. Trujillo established the Pan-American Society of Neurovirology in the year 2000 as an effort to bring together scientists across the Americas, especially Latin America, to understand the impact of viral infections on the nervous system.
As a solution-driven scientist, Dr. Trujillo is constantly drawn to the latest research and advancements in biomedical technology. Over the years, he has collaborated with leading scientists to find solutions to diseases through biomedical innovations. In 2012, he co-created CerCa, a photodynamic therapeutic medical device that could help treat the human papillomavirus (HPV) and prevent cervical cancer. Dr. Trujillo’s current focus with NeuroCytonix is advancing research into regenerative technology for neurological conditions such as cerebral palsy, autism, stroke, traumatic brain injury (TBI), vascular dementia, and the neurological impacts of COVID-19.
Over the course of 30 years, Dr. Trujillo has been on various scientific editorial boards and has published more than 60 scientific manuscripts and reviews in neurosciences and molecular virology. He has held academic posts at prestigious institutions such as Harvard University, the National Institute of Neurological Disorders and Stroke (NIH), and the University of Maryland.
Since 2010, he has founded and raised support for several biotech companies in the biotechnological corridor of the state of Maryland and Latin American markets. Dr. Trujillo has received several awards and honors for his services to science and society. His work continues to inspire and impress people. He is a leader who wishes to relentlessly contribute to areas of research, biomedical technology, and societal welfare.
